Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Umehara

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Oral Rehabilitation|April 15, 2024
Effect of physical frailty on maximum phonation time in community-dwelling older individuals who visited a neurology outpatient clinicKen Umehara, Akio Yamamoto, Takeo Kitagawa, et al.
The Journal of Toxicological Sciences|March 3, 2024
Possible nonimmunological toxicological mechanisms of vesnarinone-associated agranulocytosis in HL-60 cells: role of reduced glutathione as cytotoxic defenseToshihisa Koga, Yuko Sahara, Tadaaki Ohtani, et al.
Biological & Pharmaceutical Bulletin|November 5, 2014
Delamanid does not inhibit or induce cytochrome p450 enzymes in vitroYoshihiko Shimokawa, Katsunori Sasahara, Noriaki Yoda, et al.
Biochemical and Biophysical Research Communications|November 18, 2018
Alleviation of fatty liver in a rat model by enhancing N<sup>1</sup>-methylnicotinamide bioavailability through aldehyde oxidase inhibitionKenji Takeuchi, Chie Yokouchi, Hirohiko Goto, et al.
Biological & Pharmaceutical Bulletin|June 23, 2015
Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver MicrosomesYoshihiko Shimokawa, Noriaki Yoda, Satoshi Kondo, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 15, 2013
Hemodialysis clearance of iosimenol, a novel iso-osmolar radiographic contrast mediumYukihiro Hirao, Eiji Kashiyama, Ken Umehara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2015
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In VivoKatsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, et al.
Drug Metabolism and Pharmacokinetics|June 5, 2021
Feature importance of machine learning prediction models shows structurally active part and important physicochemical features in drug designKatsunori Sasahara, Masakazu Shibata, Hiroyuki Sasabe, et al.
Biopharmaceutics & Drug Disposition|January 17, 2017
Absorption, distribution and excretion of the anti-tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosisMasakazu Shibata, Yoshihiko Shimokawa, Katsunori Sasahara, et al.
British Journal of Neurosurgery|November 21, 2018
Dysphagia following C1 laminectomy and posterior atlantoaxial fixation for retro-odontoid pseudotumor: a case reportSatoru Tanioka, Keita Kuraishi, Masaki Mizuno, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Oral Rehabilitation|April 15, 2024
Effect of physical frailty on maximum phonation time in community-dwelling older individuals who visited a neurology outpatient clinicKen Umehara, Akio Yamamoto, Takeo Kitagawa, et al.
The Journal of Toxicological Sciences|March 3, 2024
Possible nonimmunological toxicological mechanisms of vesnarinone-associated agranulocytosis in HL-60 cells: role of reduced glutathione as cytotoxic defenseToshihisa Koga, Yuko Sahara, Tadaaki Ohtani, et al.
Biological & Pharmaceutical Bulletin|November 5, 2014
Delamanid does not inhibit or induce cytochrome p450 enzymes in vitroYoshihiko Shimokawa, Katsunori Sasahara, Noriaki Yoda, et al.
Biochemical and Biophysical Research Communications|November 18, 2018
Alleviation of fatty liver in a rat model by enhancing N<sup>1</sup>-methylnicotinamide bioavailability through aldehyde oxidase inhibitionKenji Takeuchi, Chie Yokouchi, Hirohiko Goto, et al.
Biological & Pharmaceutical Bulletin|June 23, 2015
Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver MicrosomesYoshihiko Shimokawa, Noriaki Yoda, Satoshi Kondo, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 15, 2013
Hemodialysis clearance of iosimenol, a novel iso-osmolar radiographic contrast mediumYukihiro Hirao, Eiji Kashiyama, Ken Umehara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2015
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In VivoKatsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, et al.
Drug Metabolism and Pharmacokinetics|June 5, 2021
Feature importance of machine learning prediction models shows structurally active part and important physicochemical features in drug designKatsunori Sasahara, Masakazu Shibata, Hiroyuki Sasabe, et al.
Biopharmaceutics & Drug Disposition|January 17, 2017
Absorption, distribution and excretion of the anti-tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosisMasakazu Shibata, Yoshihiko Shimokawa, Katsunori Sasahara, et al.
British Journal of Neurosurgery|November 21, 2018
Dysphagia following C1 laminectomy and posterior atlantoaxial fixation for retro-odontoid pseudotumor: a case reportSatoru Tanioka, Keita Kuraishi, Masaki Mizuno, et al.
Pageof 4